Allied Corp. Form 8-K: Current report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2025-02-05: Form 8-K; Period of report 2025-02-03; Description 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; Details 5.02.
- 2025-01-22: Form 8-K; Period of report 2025-01-21; Description 8.01 Other Events; Details 8.01.
- 2024-11-18: Form 8-K; Period of report 2024-11-18; Description 8.01 Other Events; Details 8.01.
- 2024-10-15: Form 8-K; Period of report 2024-09-26; Description 1.01 Entry into a Material Definitive Agreement; Details 1.01.
| Filed | Form | Period of report | Description | Details | Document |
|---|---|---|---|---|---|
| 2025-02-05 | 8-K | 2025-02-03 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On February 3, 2025 but effective January 30, 2025, Calum Hughes resigned as Chief Executive Officer and a Director of the Company. | alid_8k.htm |
| 2025-01-22 | 8-K | 2025-01-21 | 8.01 Other Events | 8.01 On January 21, 2025, Allied Corp. (the “Company”) issued the press release attached hereto as Exhibit 99.1. | alid_8k.htm |
| 2024-11-18 | 8-K | 2024-11-18 | 8.01 Other Events | 8.01 On November 18, 2024, Allied Corp. (the “Company”) issued the press release attached hereto as Exhibit 99.1. | alid_8k.htm |
| 2024-10-15 | 8-K | 2024-09-26 | 1.01 Entry into a Material Definitive Agreement | 1.01 Entry into a Material Definitive Agreement. | alid_8k.htm |
| 2024-09-24 | 8-K | 2024-09-24 | 8.01 Other Events | 8.01 On September 24, 2024, Allied Corp. (the “Company”) issued the press release attached hereto as Exhibit 99.1. | alid_8k.htm |
| 2024-09-13 | 8-K | 2024-08-21 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On August 21, 2024, effective August 19, 2024, the Company and Ryan Maarschalk entered into a Termination Agreement pursuant to which Mr. Maarschalk ceased to be Chief Financial Officer of the Company. | alid_8k.htm |
| 2024-07-01 | 8-K | 2024-05-29 | 8.01 Other Events | 8.01 On May 29, 2024, Allied Corp. (the “Company”) issued the press release attached hereto as Exhibit 99.1. | alid_8k.htm |
| 2024-03-27 | 8-K | 2024-03-20 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 8.01 Other Events | 5.02 Effective March 20, 2024 Santiago Ribero resigned as a Director of Allied Corp. Mr. Ribero has moved to the United States and has taken a position in the banking industry, but will continue to have an active role with the Company. 8.01 Effective March 24, 2024, the Company moved its headquarters to Suite 200 - 460 Doyle ave Kelowna BC Canada V1Y OC2. | alid_8k.htm |
| 2023-12-05 | 8-K | 2023-11-09 | 1.01 Entry into a Material Definitive Agreement | 1.01 Entry into a Material Definitive Agreement. | alid_8k.htm |
| 2023-12-05 | 8-K | 2023-11-03 | 1.01 Entry into a Material Definitive Agreement | 1.01 Entry into a Material Definitive Agreement. | alid_8k.htm |
| 2023-12-05 | 8-K | 2023-08-31 | 1.01 Entry into a Material Definitive Agreement | 1.01 Entry into a Material Definitive Agreement. | alid_8k.htm |
| 2022-07-27 | 8-K | 2022-07-20 | 4.01 Changes in Registrant's Certifying Accountant | 4.01 (a) On July 20, 2022 Allied Corp. (the “Registrant” or the “Company”) notified Manning Elliott LLP (“Manning Elliott”) that it was terminated as the Registrant’s independent registered public accounting firm. | alid_8k.htm |
| 2022-04-29 | 8-K | 2022-04-28 | 1.01 Entry into a Material Definitive Agreement | 1.01 Entry into a Material Definitive Agreement. | alid_8k.htm |
| 2021-12-07 | 8-K | 2021-12-02 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 Effective December 2, 2021 Allied Corp announced the appointment of Jay McMillan as Chief Commercial Officer (Consumer Packaged Goods) for Allied. | alid_8k.htm |
| 2021-04-09 | 8-K | 2021-03-30 | 1.01 Entry into a Material Definitive Agreement | 1.01 Entry into a Material Definitive Agreement. | alid_8k.htm |
| 2020-10-07 | 8-K | 2019-08-29 | 1.01 Entry into a Material Definitive Agreement; 2.01 Completion of Acquisition or Disposition of Assets | 1.01 Entry into a Material Definitive Agreement. 2.01 The Company closed and completed the acquisition of Baleno and Medicolumbia referenced under Item 1.01 on February 17, 2020. | alid_8k.htm |
| 2020-06-25 | 8-K/A | 2019-11-12 | 4.01 Changes in Registrant's Certifying Accountant; 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 4.01 Effective November 12, 2019, Allied Corp. (the “Company,” “we,” “us,” or “our”) determined to change our auditors to the firm who had audited our operating subsidiary and consequently terminated Marcum LLP as our independent accountant. 5.03 In connection with the Reorganization and Stock Purchase Agreement (the “Reorganization Agreement”) by and between Allied Corp, formerly known as Cosmo Ventures, Inc., a Nevada Corporation (“Allied“) and AM (Advanced Micro) Biosciences, Inc., a British Columbia company (“AM Biosciences”) as previously reported on Form 8-K, filed on September 10, 2019, effective November 12, 2019, our board of directors approved a change of our fiscal year end to August 31, the fiscal year end of our operating company AM Biosciences. | alid_8ka.htm |
| 2020-06-23 | 8-K/A | 2019-11-12 | 4.01 Changes in Registrant's Certifying Accountant; 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 4.01 Effective November 12, 2019, Allied Corp. (the “Company,” “we,” “us,” or “our”) determined to change our auditors to the firm who had audited our operating subsidiary and consequently terminated Marcum LLP as our independent accountant. 5.03 In connection with the Reorganization and Stock Purchase Agreement (the “Reorganization Agreement”) by and between Allied Corp, formerly known as Cosmo Ventures, Inc., a Nevada Corporation (“Allied“) and AM (Advanced Micro) Biosciences, Inc., a British Columbia company (“AM Biosciences”) as previously reported on Form 8-K, filed on September 10, 2019, effective November 12, 2019, our board of directors approved a change of our fiscal year end to August 31, the fiscal year end of our operating company AM Biosciences. | alid_8ka.htm |
| 2020-05-20 | 8-K | 2020-05-20 | 8.01 Other Events | 8.01 The Company will be relying on the Securities and Exchange Commission's Order under Section 36 of the Securities Exchange Act of 1934 Granting Exemptions From Specified Provisions of the Exchange Act and Certain Rules Thereunder dated March 4, 2020 (Release No. 34-88318) (the "Order") to delay the filing of its Quarterly Report on Form 10-Q for the quarter ended February 29, 2020 (the "February 10-Q") due to the circumstances related to COVID-19. | alid_8k.htm |
| 2020-05-08 | 8-K | 2020-05-02 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 Effective May 2, 2020 Allied Corp announced the appointment of Jim Smeeding, RPh, MBA, to the Company’s Board of Directors. | alid_8k.htm |
| 2020-04-15 | 8-K | 2020-04-15 | 8.01 Other Events | 8.01 The Company will be relying on the Securities and Exchange Commission’s Order under Section 36 of the Securities Exchange Act of 1934 Granting Exemptions From Specified Provisions of the Exchange Act and Certain Rules Thereunder dated March 4, 2020 (Release No. 34-88318) (the “Order”) to delay the filing of its Quarterly Report on Form 10-Q for the quarter ended February 29, 2020 (the “February 10-Q”) due to the circumstances related to COVID-19. | alid_8k.htm |
| 2020-04-03 | 8-K | 2020-03-24 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 Effective March 24, 2020 Allied Corp. accepted the resignation of Malcolm Davidson as Chief Financial Officer of the Company. | alid_8k.htm |
| 2020-03-24 | 8-K | 2020-03-18 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 Effective March 18, 2020 Allied Corp. accepted the resignation of David Weinkauf as a director and the resignation of Anthony Zelen as a director of the Company. | alid_8k.htm |
| 2019-11-29 | 8-K/A | 2019-09-10 | 9.01 Financial Statements and Exhibits | 9.01 Balance Sheet of AM (Advanced Micro) Biosciences Inc. as of August 31, 2019, and the related statements of operations and comprehensive loss, stockholders’ equity and cash flows for the period from incorporation on September 13, 2018 to August 31, 2019. | alid_8ka.htm |
| 2019-11-15 | 8-K | 2019-11-12 | 4.01 Changes in Registrant's Certifying Accountant; 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 4.01 Effective November 12, 2019, Allied Corp. (the “Company,” “we,” “us,” or “our”) determined to change our auditors to the firm who had audited our operating subsidiary and consequently terminated Marcum LLP as our independent accountant. 5.03 In connection with the Reorganization and Stock Purchase Agreement (the “Reorganization Agreement”) by and between Allied Corp, formerly known as Cosmo Ventures, Inc., a Nevada Corporation (“Allied “) and AM (Advanced Micro) Biosciences, Inc., a British Columbia company (“AM Biosciences”) as previously reported on Form 8-K, filed on September 10, 2019, effective November 12, 2019, our board of directors approved a change of our fiscal year end to August 31, the fiscal year end of our operating company AM Biosciences. | alid_8k.htm |
| 2019-10-11 | 8-K | 2019-10-02 | 1.01 Entry into a Material Definitive Agreement; 8.01 Other Events | 1.01 On October 2, 2019, Allied Corp. (the “Company”) entered into a Distribution Agreement with CBD Group Asia Limited. 8.01 On October 3, 2019, Allied Corp. (the “Company”) issued the press release attached hereto as Exhibit 99.1. | alid_8k.htm |
| 2019-09-10 | 8-K | 2019-09-10 | 1.01 Entry into a Material Definitive Agreement; 2.01 Completion of Acquisition or Disposition of Assets; 3.02 Unregistered Sales of Equity Securities; 5.01 Changes in Control of Registrant; 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; 8.01 Other Events | 1.01 On July 25, 2019, as amended effective August 27, 2019, Allied Corp, formerly known as Cosmo Ventures, Inc., a Nevada Corporation (“Allied “) entered into a Reorganization and Stock Purchase Agreement (the “Reorganization Agreement”) to acquire 100% of the issued and outstanding equity of AM (Advanced Micro) Biosciences, Inc., a British Columbia company (“AM Biosciences”). 2.01 Pursuant to the Reorganization Agreement, effective on September 10, 2019, Allied acquired 100% of the issued and outstanding equity of AM Biosciences from the shareholders of AM Biosciences. 3.02 Effective August 3, 2019, upon notice to and review by FINRA, the Company completed a 5.666 shares for each one share dividend (accounted for in our financial statements as a one for 6.666 forward stock split), resulting in the issuance of 73,658,000 additional shares of common stock. 5.01 Pursuant to the Reorganization Agreement, the Allied Shareholder delivered 55,700,014 shares of common stock, representing approximately 73.2% of the outstanding equity of Allied Corp. to SECFAC Exchange Corp. on behalf of the previous shareholders of AM Biosciences and other designees of AM Biosciences, resulting in a change of control of the Registrant. 8.01 As a result of the Reorganization Agreement, Allied Corp. has altered its primary operation. | alid_8k.htm |
| 2018-08-09 | 8-K | 2018-08-07 | 4.01 Changes in Registrant's Certifying Accountant | 4.01 On August 7, 2018, Cosmo Ventures Inc. (the “Company”) accepted the resignation of GBH CPAs, PC (“GBH”) and engaged Marcum LLP (“Marcum”) as its independent registered public accountants. | csmo_8k.htm |
| 2018-06-08 | 8-K | 2018-06-08 | 5.01 Changes in Control of Registrant; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.01 Cosmo Ventures Inc. (“Cosmo Ventures” or the “Company”) was incorporated in the State of Nevada on February 3, 2013. 5.02 On February 28, 2018, Mr. Sonu Ram resigned as director and all executive officer positions with the Company. | csmo_8k.htm |
| 2018-03-02 | 8-K | 2018-02-28 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On February 28, 2018, Mr. Sonu Ram resigned as director and all executive officer positions with the Company. | csmo_8k.htm |
| 2016-12-14 | 8-K | 2016-12-14 | 4.01 Changes in Registrant's Certifying Accountant | 4.01 (A) PREVIOUS INDEPENDENT ACCOUNTANTS. | csmo_8k.htm |